openPR Logo
Press release

Menopausal Hot Flashes Market: Significant Increase in Vasomotor Symptoms in Women to Create Growth Opportunities

11-23-2017 08:10 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Menopausal Hot Flashes Market: Significant Increase

The global market for menopausal hot flashes is a moderately fragmented market, in which the top eight players collectively held a share of more than 50% in 2014, states a new research study by Transparency Market Research (TMR). Novartis AG and Pfizer Inc., the top two vendors, which accounted for nearly 30% of this market in 2014, are expected to maintain their stronghold over the next few years. Pfizer is expected to gain from its robust presence across North America while Novartis will benefit from its wide-ranging product portfolio for the treatment of menopausal hot flashes in the years to come, notes the study.

Read Report Overview @ https://www.transparencymarketresearch.com/menopausal-hot-flashes.html

According to this report, the total opportunity in the global menopausal hot flashes market was US$3.77 bn in 2014. Researchers predict this market to rise at a CAGR of 3.70% during the period from 2015 to 2023 and increase to US$5.28 bn by the end of the forecast period.

According to the report, hormonal products have been witnessing an overwhelming demand across the world, as people prefer hormone replacement therapies for the treatment of menopausal hot flashes. In 2014, the hormonal products segment held a staggering 95% of the overall market and is anticipated to continue on the same track over the next few years. Non-hormonal products, however, are expected to gain momentum in the near future, since the awareness regarding the harmful effects hormonal therapies on women’s health is increasing considerably.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2856

In terms of the geography, the global market for menopausal hot flashes is led by North America, reports the study. The increasing incidence of menopausal vasomotor symptoms in the female population in this region is the key factor behind the growth of this market in North America. In 2014, the regional market acquired a share of 66% in the overall market and is projected to remain on the top over the period of the forecast.

Amongst others, the menstrual hot flashes market in Asia Pacific is anticipated to outshine in terms of value and volume in the next few years due to the rising awareness pertaining to menopause-related health issues and the increasing disposable income of consumers in this region.

Request Menopausal Hot Flashes Market Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2856

“The global market for menopausal hot flashes is gaining substantial impetus from the rising instances of night sweats caused by menopause and vasomotor symptoms, commonly known as, hot flashes,” says the author of this study. The increasing number of favorable initiatives commenced by several governments and private healthcare institutes to raise the awareness regarding women’s health among people across the world is another important factor that is boosting this market.

Going forward, the speedy approval of new treatments is expected to create new streams for revenue generation for market players in the near future. However, the increasing availability of alternative therapies at a much cheaper rate may limit the growth of this market over the forecast period, states the resesrch report.

Buy Full Menopausal Hot Flashes Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=2856<ype=S

About TMR

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Menopausal Hot Flashes Market: Significant Increase in Vasomotor Symptoms in Women to Create Growth Opportunities here

News-ID: 829719 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Menopausal

Menopausal Hot Flashes Market Research Report 2017 to 2021
Global Menopausal Hot Flashes Market 2017 to 2021 Exploration Report gives the most up to date industry information and future industry trends, enabling you to recognize the types and end clients driving development and productivity. The analysis gives a simple summary of this Menopausal Hot Flashes industry for example definitions, classes, software, and industry series arrangement, and development plans and policies are all discussed in addition to manufacturing processes and cost arrangements.
Menopausal Hot Flashes Market | Analysis and Key Trends 2023
The global market for menopausal hot flashes is a moderately fragmented market, in which the top eight players collectively held a share of more than 50% in 2014, states a new research study by Transparency Market Research (TMR). Novartis AG and Pfizer Inc., the top two vendors, which accounted for nearly 30% of this market in 2014, are expected to maintain their stronghold over the next few years. Pfizer is
Menopausal Disorders Market to observe high growth by 2024
Being one of the most physically-draining time in women’s lives has urged global pharmaceutical giants towards development of effective drugs for treating menopause and related disorders. In women, menopause or climacteric period occurs when menstrual periods stop occurring in their life, permanently. During this time, the female body undergoes several drastic changes that result into occurrence of several disorders. The need to treat menopausal disorders is gaining momentum across all
Menopausal Disorders Market 2024: Business Development Analysis
Being one of the most physically-draining time in women’s lives has urged global pharmaceutical giants towards development of effective drugs for treating menopause and related disorders. In women, menopause or climacteric period occurs when menstrual periods stop occurring in their life, permanently. During this time, the female body undergoes several drastic changes that result into occurrence of several disorders. The need to treat menopausal disorders is gaining momentum across all
Rising Prevalence of Menopausal Vasomotor Symptoms Remains Key Vehicle for Menop …
Menopausal Hot Flashes Market: Snapshot A substantial rise in occurrence of vasomotor symptoms or hot flashes and night sweats resulting from menopause is the single most important growth driver in the global menopausal hot flashes market. Another factor creating demand in the market is the favorable initiatives undertaken by governments and private healthcare institutes in raising awareness about women’s health. Fettering the positive effect of such growth drivers in the market
Post-menopausal Osteoporosis Market : Applications and Global Markets
Factors such as aging population, decline in estrogen levels after menopause, lifestyle changes such as smoking and alcohol consumption, and increase in bone loss after menopause are projected to drive the post-menopausal osteoporosis market globally. Mergers & acquisitions and new product innovation are another fueling factors which are expected to add value to the post-menopausal osteoporosis market. On other hand, high standards regulatory approval of any new product launch into